189.65 +0.15 (0.08%)
After hours: 7:54PM EDT
|Bid||0.00 x 1300|
|Ask||0.00 x 800|
|Day's Range||189.20 - 190.89|
|52 Week Range||166.64 - 217.62|
|PE Ratio (TTM)||11.76|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||233.50|
Warren Buffett, Jeff Bezos, and Jamie Dimon have found their CEO. Dr. Atul Gawande has been named CEO of the health care company founded by Berkshire Hathaway, Amazon, and JPMorgan in an effort to push down health care costs. Yahoo Finance’s Seana Smith, Dan Roberts and Myles Udland discuss.
Berkshire Hathaway Inc., Amazon.com Inc. and JPMorgan Chase & Co. named prominent surgeon and researcher Atul Gawande as chief executive of their new venture that aims to overhaul workers’ health care. The appointment of Dr. Gawande is effective July 9, and the still-unnamed health-care initiative will be based in Boston, the companies said. The selection of Dr. Gawande, a best-selling author known for his work on health-care quality, ensures the effort will remain under a spotlight, and provides the most concrete signal so far that the partners’ ambitions go beyond conventional tweaks to employer health-benefit plans.
Well-regarded surgeon and author Atul Gawande, a critic of his industry's medical practices, will lead the new company being formed by Amazon.com Inc (AMZN.O), Berkshire Hathaway Inc (BRKa.N) and JPMorgan Chase & Co (JPM.N) that aims to cut U.S. employee healthcare costs, the companies said on Wednesday. Amazon, Berkshire and JPMorgan announced the joint venture in January, saying U.S. healthcare costs were rising too fast and holding back economic growth.
Moody's Investors Service, ("Moody's") affirmed the ratings of PacifiCorp, including its Issuer and senior unsecured ratings at A3, its senior secured at A1, its preferred stock at Baa2, and it short-term ratings for commercial paper and variable rate revenue bonds at P-2. The rating outlook for PacifiCorp is stable.
Dr. Atul Gawande, an accomplished surgeon, writer and Harvard professor, has been named the chief executive officer of a new health-care initiative started by Amazon.com Inc., Berkshire Hathaway Inc. and JPMorgan Chase & Co. The new independent venture has as its goal improving health care for the three companies’ more than a million combined U.S. employees, as well as making it more cost-effective. “We said at the outset that the degree of difficulty is high and success is going to require an expert’s knowledge, a beginner’s mind, and a long-term orientation,” Amazon Chief Executive Jeff Bezos said in the Wednesday release.
Dr. Atul Gawande soon will lead the joint venture between J.P. Morgan, Amazon and Berkshire Hathaway. J.P. Morgan CEO Jamie Dimon, Amazon Chief Jeff Bezos and Berkshire leader Warren Buffett announced the venture in January. Dr. Atul Gawande writes and speaks about health care — a lot.
Warren Buffett, the chief executive of Berkshire Hathaway Inc. , has long been lauded as one of the greatest value investors of this lifetime. That makes his picks for Berkshire a solid pick for a retirement fund with a few years to grow.
Three corporate giants seeking to attack rising health care costs have turned to a Harvard professor who has written books about the system's many flaws.
Dr. Atul Gawande was once given $20,000 by Warren Buffett's longtime investing partner Charlie Munger. Buffett, chairman and CEO of Berkshire Hathaway, made that revelation on CNBC back in 2010. At the time, Buffett said Munger wrote a check after Gawande published an article in The New Yorker on high U.S. medical costs.
Well-regarded surgeon and author Atul Gawande, a critic of his industry's medical practices, will lead the new company being formed by Amazon.com Inc, Berkshire Hathaway Inc and JPMorgan Chase & Co that aims to cut U.S. employee healthcare costs, the companies said on Wednesday. Amazon, Berkshire and JPMorgan announced the joint venture in January, saying U.S. healthcare costs were rising too fast and holding back economic growth.
Warren Buffett has consistently ranked highly on Forbes' list of billionaires. In June 2006, Buffett announced his plans to donate his entire fortune to charity. In 2012 Buffett shared that he had been diagnosed with prostate cancer.
Executives from Amazon, JPMorgan Chase, and Berkshire Hathaway have named doctor Atul Gawande the CEO of their joint healthcare company, a startup announced in January that’s intended to serve as an alternative medical system for the companies’ employees. Gawande has a long history of criticizing healthcare in the US. In addition to being a surgeon…
Professor Atul Gawande, M.D. delivers speech during Geisinger Health System A Century of Transformation and Innovation Symposium at Pine Barn Inn on September 25, 2015 in Danville, Pennsylvania. News that Amazon, Warren Buffett and JPMorgan Chase & Co. have picked noted surgeon, speaker and writer Dr. Atul Gawande to run their healthcare venture has the business community wondering what his solutions will be to fix healthcare.
Amazon, Berkshire Hathaway and JPMorgan have named surgeon and journalist Atul Gawande the CEO of their new healthcare company https://bloom.bg/2ysThJj #tictocnews (Source: Bloomberg)
Amazon.com, Inc. (NASDAQ: AMZN ), Berkshire Hathaway Inc. Class A (NYSE: BRK-A ) (NYSE: BRK-B ) and JPMorgan Chase & Co. (NYSE: JPM ) are making strides in their joint plan to transform U.S. health care. ...
chief Warren Buffett may be making: $2 trillion Apple valuation. "He clearly views it as a long-term hold, and it will certainly compound over $1 trillion in the not too distant future -- and then double again in the next five years," says former hedge fund manager and Buffett expert Whitney Tilson. The billionaire's holding conglomerate Berkshire Hathaway hiked its stake in Apple by a whopping 23% to 165.3 million shares in the fourth quarter, according to a filing earlier in the year.
In January, the CEOs of Berkshire Hathaway Inc. ( BRK.A), JPMorgan Chase & Co. ( JPM) and Amazon.com Inc. ( AMZN) announced plans to team up for a partnership intended to reduce the rising cost of health care for employees. Dr. Atul Gawande will serve as CEO of the company, which the group says will be "free from profit-making incentives and constraints." Gawande, who currently practices general and endocrine surgery at Boston's Brigham and Women's Hospital and is a professor at the Harvard T.H. Chan School of Public Health and Harvard Medical School, will assume the position on July 9.
The company also announced a local CEO: Dr. Atul Gawande, who currently works as a general and endocrine surgeon at Brigham and Women’s Hospital, and as a professor in the Harvard T.H. Chan School of Public Health and Harvard Medical School.
The latest disruptor to the U.S. healthcare industry officially has a leader. named Dr. Atul Gawande as the CEO of their joint partnership designed to tackle U.S. employee healthcare. The still unnamed company will be headquartered in Boston and will operate as a non-profit organization.
Dr. Atul Gawande, an accomplished surgeon, writer and Harvard professor, has been named the chief executive officer of a new initiative started by Amazon.com Inc. , Berkshire Hathaway Inc. and J.P. Morgan Chase & Co. , with the goal of improving health care for their more than a million combined U.S. employees, as well as making it more cost-effective. The initiative has been expected to shake up the status quo, and even sent shares of companies across the health care industry tumbling after the late January announcement. Previous reports pegged David Feinberg, the chief executive of Geisinger Health System, as the top candidate.
Atul Gawande, a surgeon and journalist who has written extensively about the U.S. failure to grapple with rising health-care spending, has been named to head a new health venture for Amazon.com Inc., Berkshire Hathaway Inc. and JPMorgan Chase & Co. The new firm -- meant to help the three companies improve care and lower costs -- will be based in Boston and Gawande will start on July 9. It will be independent from the three firms, whose leaders formed the group as a way of contending with what Berkshire Chief Executive Officer Warren Buffett called a “tapeworm” eating the U.S. economy.